In 2026, several clinical studies evaluated artificial intelligence in breast cancer screening, going beyond retrospective testing alone. The randomized MASAI trial reports fewer cancers detected between two screening rounds, while other studies show possible gains…
Launched by Google DeepMind on September 8, 2026, AlphaGenome Atlas makes available predictions of the molecular effects of nine billion possible single-letter substitutions in the human genome. These are neither nine billion mutations observed in…
For a long time, the idea of directly converting a thought into text belonged to the realm of science fiction. Brain-machine interfaces were limited to specialized laboratories or relied on brain implants that required surgery….
